BRISTOL MYERS SQUIBB CO Quarterly Interest Expense in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Bristol Myers Squibb Co quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q1 2024.
  • Bristol Myers Squibb Co Interest Expense for the quarter ending March 31, 2024 was $425M, a 47.6% increase year-over-year.
  • Bristol Myers Squibb Co Interest Expense for the twelve months ending March 31, 2024 was $1.3B, a 9.13% increase year-over-year.
  • Bristol Myers Squibb Co annual Interest Expense for 2023 was $1.17B, a 5.36% decline from 2022.
  • Bristol Myers Squibb Co annual Interest Expense for 2022 was $1.23B, a 7.65% decline from 2021.
  • Bristol Myers Squibb Co annual Interest Expense for 2021 was $1.33B, a 6.06% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.3B $425M +$137M +47.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $1.17B $316M +$22M +7.48% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-13
Q3 2023 $1.14B $280M -$19M -6.36% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $1.16B $282M -$31M -9.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $1.19B $288M -$38M -11.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $1.23B $294M -$29M -8.98% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-13
Q3 2022 $1.26B $299M -$29M -8.84% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $1.29B $313M -$17M -5.15% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $1.31B $326M -$27M -7.65% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $1.33B $323M -$32M -9.01% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-13
Q3 2021 $1.37B $328M -$18M -5.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $1.38B $330M -$27M -7.56% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 $1.41B $353M -$9M -2.49% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $1.42B $355M +$76M +27.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-14
Q3 2020 $1.34B $346M +$137M +65.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-27
Q2 2020 $1.21B $357M +$234M +190% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $973M $362M +$317M +704% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $656M $279M +$231M +481% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-09
Q3 2019 $425M $209M +$165M +375% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $260M $123M +$78M +173% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $182M $45M -$1M -2.17% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $183M $48M -$3M -5.88% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-10
Q3 2018 $186M $44M -$4M -8.33% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $190M $45M -$7M -13.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-25
Q1 2018 $197M $46M +$1M +2.22% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-25
Q4 2017 $196M $51M +$11M +27.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $185M $48M +$6M +14.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-25
Q2 2017 $179M $52M +$10M +23.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-26
Q1 2017 $169M $45M +$2M +4.65% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q4 2016 $167M $40M -$3M -6.98% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-25
Q3 2016 $170M $42M +$1M +2.44% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $169M $42M -$7M -14.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $176M $43M -$8M -15.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $184M $43M -$10M -18.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $194M $41M -$9M -18% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 $203M $49M +$3M +6.52% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $200M $51M -$3M -5.56% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 $203M $53M $0 0% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-21
Q3 2014 $203M $50M +$4M +8.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $199M $46M -$4M -8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-23
Q1 2014 $203M $54M +$4M +8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 $199M $53M +$2M +3.92% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-12
Q3 2013 $197M $46M -$2M -4.17% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-24
Q2 2013 $199M $50M +$9M +22% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-24
Q1 2013 $190M $50M +$8M +19% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 $182M $51M +$9M +21.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-13
Q3 2012 $173M $48M +$8M +20% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-23
Q2 2012 $165M $41M +$9M +28.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $156M $42M +$11M +35.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 $145M $42M $0 0% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-14
Q3 2011 $145M $40M +$2M +5.26% Jul 1, 2011 Sep 30, 2011 10-Q 2011-10-27
Q2 2011 $143M $32M $0 0% Apr 1, 2011 Jun 30, 2011 10-Q 2011-07-28
Q1 2011 $143M $31M -$2M -6.06% Jan 1, 2011 Mar 31, 2011 10-Q 2011-04-28
Q4 2010 $145M $42M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-15
Q3 2010 $38M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 $32M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 $33M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.